Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|February 26, 2026
Improved early transplant outcomes with reduced-dose PTCy and low-dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemiaNihar Desai, Mohammed Althobaiti, Carol Chen, et al.
European Journal of Haematology|October 13, 2020
Prolactin, a potential biomarker for chronic GVHD activityMaria Queralt Salas, Shereen Ezzat, Wilson Lam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous LeukemiaMaria Queralt Salas, Shiyi Chen, Wilson Lam, et al.
Leukemia & Lymphoma|August 26, 2021
Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infectionsMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 8, 2021
Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute LeukemiaEshrak Al-Shaibani, Sunu Cyriac, Shiyi Chen, et al.
European Journal of Haematology|June 2, 2021
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CRIgor Novitzky-Basso, Carol Chen, Shiyi Chen, et al.
Leukemia Research|September 21, 2023
Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failureSwe Mar Linn, Igor Novitzky-Basso, Christopher Patriquin, et al.
Hematology/Oncology and Stem Cell Therapy|October 13, 2020
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantationRam Vasudevan Nampoothiri, Shiyi Chen, Ivan Pasic, et al.
Leukemia & Lymphoma|May 14, 2026
CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysisVered Stavi, Carol Chen, Igor Novitzky-Basso, et al.
European Journal of Haematology|July 14, 2021
Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosisSunu Cyriac, Shruti Prem, Maria Queralt Salas, et al.
Pageof 13